Dana Matzen
Plus aucun poste en cours
Fortune : 3 400 $ au 31/05/2024
Profil
Dana Matzen worked as Director of Business Development at Paladin Labs, Inc. from 2010 to 2016.
From 2016 to 2023, she served as Vice President of Business and Corporate Development at Intelgenx Corp.
and IntelGenx Technologies Corp.
respectively.
Matzen holds a graduate degree from the University of Kiel and a doctorate from Technische Universität Wien.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/01/2023 | 85 000 ( 0,05% ) | 3 400 $ | 31/05/2024 |
Anciens postes connus de Dana Matzen
| Sociétés | Poste | Fin |
|---|---|---|
Intelgenx Corp.
 Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Corporate Officer/Principal | 10/03/2023 |
| INTELGENX TECHNOLOGIES CORP. | Corporate Officer/Principal | 01/03/2023 |
| PALADIN LABS INC. | Corporate Officer/Principal | 01/03/2016 |
Formation de Dana Matzen
| Technische Universität Wien | Doctorate Degree |
| University of Kiel | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INTELGENX TECHNOLOGIES CORP. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
